Chua Gilbert T, Chan Edmond S
From the Department of Paediatrics and Adolescent Medicine, The University of Hong Kong, Hong Kong SAR, China.
Division of Allergy and Immunology, Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada; and.
J Food Allergy. 2022 Jul 1;4(2):144-147. doi: 10.2500/jfa.2022.4.220006. eCollection 2022 Jul.
Legumes other than peanut are an important source of protein and consist of a wide variety of species, such as soy, peas, chickpeas, lentils, and lupin. Due to their health benefits and the rising popularity of veganism, legume consumption has increased. Legume allergy, cross-sensitization, and cross-reactivity between different species have been reported in the literature and are increasingly recognized. Unlike peanut, oral immunotherapy (OIT) for nonpeanut legumes has not been well studied and published protocols are lacking. Future studies are needed to provide real-world data on the safety and effectiveness of nonpeanut legume OIT, and whether desensitization to one legume leads to desensitization to other legumes in patients with multiple legume allergy. Nevertheless, due to the abundance of clinical trial and real-world data for peanut OIT, it is reasonable to use protocols that substitute peanut protein with other legume protein when desensitizing individuals with nonpeanut legume allergy. Clinicians who are starting to offer legume OIT in their practices may consider starting with preschoolers, an age group for whom real-world data has shown the greatest safety and effectiveness.
除花生外的豆类是蛋白质的重要来源,包括多种品种,如大豆、豌豆、鹰嘴豆、小扁豆和羽扇豆。由于其对健康有益且纯素食主义日益流行,豆类的消费量有所增加。文献中已报道了不同豆类物种之间的豆类过敏、交叉致敏和交叉反应,并且这些情况越来越受到认可。与花生不同,针对非花生类豆类的口服免疫疗法(OIT)尚未得到充分研究,也缺乏已发表的方案。未来需要开展研究,以提供关于非花生类豆类OIT安全性和有效性的真实世界数据,以及在对多种豆类过敏的患者中,对一种豆类脱敏是否会导致对其他豆类脱敏。然而,由于花生OIT有大量的临床试验和真实世界数据,在对非花生类豆类过敏的个体进行脱敏时,使用用其他豆类蛋白替代花生蛋白的方案是合理的。开始在临床实践中提供豆类OIT的临床医生可能会考虑从学龄前儿童开始,对于这个年龄组,真实世界数据已显示出最大的安全性和有效性。